1. Home
  2. MFA vs CDNA Comparison

MFA vs CDNA Comparison

Compare MFA & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MFA Financial Inc.

MFA

MFA Financial Inc.

HOLD

Current Price

$9.81

Market Cap

976.0M

Sector

Real Estate

ML Signal

HOLD

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$20.02

Market Cap

712.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MFA
CDNA
Founded
1997
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical Specialities
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
976.0M
712.2M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
MFA
CDNA
Price
$9.81
$20.02
Analyst Decision
Buy
Buy
Analyst Count
7
7
Target Price
$10.96
$26.67
AVG Volume (30 Days)
1.1M
841.8K
Earning Date
11-06-2025
11-04-2025
Dividend Yield
14.80%
N/A
EPS Growth
N/A
N/A
EPS
0.86
1.22
Revenue
$279,011,000.00
$357,998,000.00
Revenue This Year
N/A
$14.11
Revenue Next Year
$14.85
$12.00
P/E Ratio
$11.32
$16.01
Revenue Growth
N/A
14.46
52 Week Low
$7.85
$10.96
52 Week High
$11.08
$25.95

Technical Indicators

Market Signals
Indicator
MFA
CDNA
Relative Strength Index (RSI) 63.06 63.66
Support Level $9.48 $19.01
Resistance Level $9.86 $20.05
Average True Range (ATR) 0.14 0.96
MACD 0.02 -0.05
Stochastic Oscillator 83.72 74.29

Price Performance

Historical Comparison
MFA
CDNA

About MFA MFA Financial Inc.

MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company's reportable segments include mortgage-related assets and Lima One.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: